Potential use of genetically modified pigs as organ donors for transplantation into humans.
1. Transplantation is currently viewed as a successful treatment for end-stage organ failure. Its more widespread use is severely limited by a shortage of human organ donors. This has stimulated the scientific and medical communities to look at the potential use of animals to solve this problem. For a number of reasons, the pig appears to be the preferred species. 2. The initial immunological problem encountered in pig-to-primate transplantation is a process of hyperacute rejection, which is mediated by the binding of antibodies to the graft endothelium followed by the activation of the complement cascade. We have sought to overcome these initial immunological challenges by focusing our attention not only on the recipient of the graft but also on the donor. Therefore, we have generated transgenic animals with specific genetic modifications designed to inhibit the activation of the complement cascade. Upon transplantation to baboons of organs derived from these transgenic pigs, we have been able to demonstrate that hyperacute rejection can be prevented. We will discuss the generation of these and other transgenic animals and their potential role in clinical xenotransplantation.
Logan
J S
JS
Nextran Incorporated, Princeton, New Jersey, USA. jlogan@nextran.com
Sharma
A
A
D000818:Animals; D030801:Animals, Genetically Modified / Q000235:genetics / Q000276:immunology; D006801:Humans; D013552:Swine / Q000235:genetics* / Q000276:immunology*; D014019:Tissue Donors; D014183:Transplantation, Heterologous / Q000276:immunology*